Abstract Details

Title A Unique Partnership for Research in Epilepsy Outcomes: The Emory University and UCB Pharma Collaboration

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 064

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Sandra L. Helmers, MD, FAAN (Emory Universtiy) PRESENTER	No disclosure on file
Sonia Khan	No disclosure on file
	No disclosure on file
David J. Thurman, MD, FAAN	No disclosure on file
R E. Faught, Jr., MD, FAAN (Emory University)	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Kelly Simontacchi (UCB Inc)	The institution of Kelly Simontacchi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jazz Pharmaceuticals.
	No disclosure on file

��ɫ����